Understanding Ultima-N-Acetyl Semax
N-Acetyl Semax is a synthetic heptapeptide representing an acetylated derivative of the original Semax compound. This modification involves the addition of an acetyl group to the N-terminus, which research indicates may enhance metabolic stability and potentially improve bioavailability characteristics compared to the unmodified peptide. As a member of the melanocortin peptide family, N-Acetyl Semax maintains the core ACTH 4-7 sequence with the characteristic Pro-Gly-Pro C-terminal extension. Researchers at Stroid UK Shop frequently investigate this compound for its neurotropic properties and unique pharmacological profile in controlled laboratory environments.
Laboratory Applications
Scientific studies examine N-Acetyl Semax for its potential modulation of brain-derived neurotrophic factor (BDNF) expression in neural tissue models. Research protocols often evaluate its effects on neurotrophic signaling pathways and investigate interactions with various neurotransmitter systems. The acetylated modification allows researchers to study enhanced peptide stability compared to non-acetylated variants. Comparative studies frequently analyze this compound alongside other research chemicals available in our miscellaneous research compounds category. Neurobiological research teams investigate potential neuroprotective mechanisms through carefully controlled experimental designs. Academic laboratories studying peptide modifications often compare N-Acetyl Semax with related compounds found in our peptides section for comprehensive analysis.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | N-Acetyl Semax |
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Purity | Research grade |
| Form | Lyophilised powder |
| Storage | 2-8°C, protect from light |
| Handling | Laboratory use only |
Research teams studying metabolic pathways often examine this compound in conjunction with modulators from our SARMs collection for comprehensive experimental protocols. The 30mg presentation provides sufficient material for multiple research sessions while maintaining compound integrity.
Research Compliance
N-Acetyl Semax from Ultima Pharmaceuticals is manufactured exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must ensure appropriate safety protocols and institutional approval before conducting studies. All experimental work should comply with relevant laboratory safety guidelines and institutional research standards. This compound is restricted to qualified research facilities with appropriate handling capabilities for peptide-based research materials.
